Company / FCF Margin
Tango Therapeutics, Inc. FCF Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-224.3%
FY2025
5-year range
-327.2% / 900.8%
FY2021-FY2025
Trend
+28.7%
vs FY2024
Sector context
#100 of 134
Health Care
What the data says
Tango Therapeutics, Inc.'s fcf margin of -224.3% is lower than 75% of companies in the Health Care sector (FY2025). Improved from -327.2% to -224.3% over the past 2 years.
Based on SEC 10-K filings.
-224.3% in FY2025 with a 3-year CAGR of -58.7%.
Improved from -327.2% to -224.3% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -58.7pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 134This company -224.3% Sector average -637.8%
▼
+64.8% above sector average
Key checks
Key Insights
- In FY2025, fcf margin increased 28.7% year-over-year.
- Currently 413.5pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2021.
- Lowest fcf margin in the period was in FY2023.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -224.3% | +28.7% |
| FY2024 | -314.4% | +3.9% |
| FY2023 | -327.2% | -97.5% |
| FY2022 | -165.7% | -118.4% |
| FY2021 | 900.8% | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026